Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3

Wendy Chang, Mark O. Goodarzi, Heith Williams, Denis A. Magoffin, Marita Pall, Ricardo Azziz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: To test the hypothesis that an abnormality in glycogen synthase kinase-3 (GSK3) is a pathogenic factor in polycystic ovary syndrome (PCOS). Design: Prospective experimental study (adipocytes). Setting: Tertiary-care academic medical center and teaching hospital. Patient(s): Twenty patients with PCOS and 21 healthy control women. Intervention(s): Blood sampling, physical exam, biopsy of SC lower abdominal fat. Main Outcome Measure(s): Glucose transport and protein levels and phosphorylation state of glycogen synthase kinase (GSK)-3α and GSK3β in adipocytes; assessment of GSK3β activity. Result(s): Basal protein levels of glycogen synthase kinase (GSK3α and GSK3β) did not differ between control women and women with PCOS, nor did basal or insulin-stimulated levels of serine phosphorylated GSK3α. However, in adipocytes of women with PCOS, insulin stimulation was not associated with increased serine phosphorylation of GSK3β, in contrast to the case of control women. Tyrosine phosphorylation of GSK3β also was higher in women with PCOS, compared with in control women. Consistent with the phosphorylation data, GSK3β activity was elevated in PCOS adipocytes. Conclusion(s): These data suggest that GSK3β is hyperactivated and resistant to down-regulation by insulin in PCOS. By using physiologic approaches, we demonstrated that abnormal GSK3β regulation is a potential mechanism for the insulin resistance that is seen in some women with PCOS, which may contribute to their development of the syndrome.

Original languageEnglish (US)
Pages (from-to)2291-2297
Number of pages7
JournalFertility and sterility
Volume90
Issue number6
DOIs
StatePublished - Dec 1 2008

Fingerprint

Glycogen Synthase Kinase 3
Polycystic Ovary Syndrome
Adipocytes
Phosphorylation
Insulin
Serine
Glycogen Synthase Kinases
Abdominal Fat
Facilitative Glucose Transport Proteins
Tertiary Healthcare
Teaching Hospitals
Tyrosine
Insulin Resistance
Research Design

Keywords

  • Glycogen synthase kinase
  • insulin resistance
  • phosphorylation
  • polycystic ovary syndrome

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. / Chang, Wendy; Goodarzi, Mark O.; Williams, Heith; Magoffin, Denis A.; Pall, Marita; Azziz, Ricardo.

In: Fertility and sterility, Vol. 90, No. 6, 01.12.2008, p. 2291-2297.

Research output: Contribution to journalArticle

Chang, Wendy ; Goodarzi, Mark O. ; Williams, Heith ; Magoffin, Denis A. ; Pall, Marita ; Azziz, Ricardo. / Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. In: Fertility and sterility. 2008 ; Vol. 90, No. 6. pp. 2291-2297.
@article{7de0c556e4bc431d9b2fd0526a4451d3,
title = "Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3",
abstract = "Objective: To test the hypothesis that an abnormality in glycogen synthase kinase-3 (GSK3) is a pathogenic factor in polycystic ovary syndrome (PCOS). Design: Prospective experimental study (adipocytes). Setting: Tertiary-care academic medical center and teaching hospital. Patient(s): Twenty patients with PCOS and 21 healthy control women. Intervention(s): Blood sampling, physical exam, biopsy of SC lower abdominal fat. Main Outcome Measure(s): Glucose transport and protein levels and phosphorylation state of glycogen synthase kinase (GSK)-3α and GSK3β in adipocytes; assessment of GSK3β activity. Result(s): Basal protein levels of glycogen synthase kinase (GSK3α and GSK3β) did not differ between control women and women with PCOS, nor did basal or insulin-stimulated levels of serine phosphorylated GSK3α. However, in adipocytes of women with PCOS, insulin stimulation was not associated with increased serine phosphorylation of GSK3β, in contrast to the case of control women. Tyrosine phosphorylation of GSK3β also was higher in women with PCOS, compared with in control women. Consistent with the phosphorylation data, GSK3β activity was elevated in PCOS adipocytes. Conclusion(s): These data suggest that GSK3β is hyperactivated and resistant to down-regulation by insulin in PCOS. By using physiologic approaches, we demonstrated that abnormal GSK3β regulation is a potential mechanism for the insulin resistance that is seen in some women with PCOS, which may contribute to their development of the syndrome.",
keywords = "Glycogen synthase kinase, insulin resistance, phosphorylation, polycystic ovary syndrome",
author = "Wendy Chang and Goodarzi, {Mark O.} and Heith Williams and Magoffin, {Denis A.} and Marita Pall and Ricardo Azziz",
year = "2008",
month = "12",
day = "1",
doi = "10.1016/j.fertnstert.2007.10.025",
language = "English (US)",
volume = "90",
pages = "2291--2297",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3

AU - Chang, Wendy

AU - Goodarzi, Mark O.

AU - Williams, Heith

AU - Magoffin, Denis A.

AU - Pall, Marita

AU - Azziz, Ricardo

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Objective: To test the hypothesis that an abnormality in glycogen synthase kinase-3 (GSK3) is a pathogenic factor in polycystic ovary syndrome (PCOS). Design: Prospective experimental study (adipocytes). Setting: Tertiary-care academic medical center and teaching hospital. Patient(s): Twenty patients with PCOS and 21 healthy control women. Intervention(s): Blood sampling, physical exam, biopsy of SC lower abdominal fat. Main Outcome Measure(s): Glucose transport and protein levels and phosphorylation state of glycogen synthase kinase (GSK)-3α and GSK3β in adipocytes; assessment of GSK3β activity. Result(s): Basal protein levels of glycogen synthase kinase (GSK3α and GSK3β) did not differ between control women and women with PCOS, nor did basal or insulin-stimulated levels of serine phosphorylated GSK3α. However, in adipocytes of women with PCOS, insulin stimulation was not associated with increased serine phosphorylation of GSK3β, in contrast to the case of control women. Tyrosine phosphorylation of GSK3β also was higher in women with PCOS, compared with in control women. Consistent with the phosphorylation data, GSK3β activity was elevated in PCOS adipocytes. Conclusion(s): These data suggest that GSK3β is hyperactivated and resistant to down-regulation by insulin in PCOS. By using physiologic approaches, we demonstrated that abnormal GSK3β regulation is a potential mechanism for the insulin resistance that is seen in some women with PCOS, which may contribute to their development of the syndrome.

AB - Objective: To test the hypothesis that an abnormality in glycogen synthase kinase-3 (GSK3) is a pathogenic factor in polycystic ovary syndrome (PCOS). Design: Prospective experimental study (adipocytes). Setting: Tertiary-care academic medical center and teaching hospital. Patient(s): Twenty patients with PCOS and 21 healthy control women. Intervention(s): Blood sampling, physical exam, biopsy of SC lower abdominal fat. Main Outcome Measure(s): Glucose transport and protein levels and phosphorylation state of glycogen synthase kinase (GSK)-3α and GSK3β in adipocytes; assessment of GSK3β activity. Result(s): Basal protein levels of glycogen synthase kinase (GSK3α and GSK3β) did not differ between control women and women with PCOS, nor did basal or insulin-stimulated levels of serine phosphorylated GSK3α. However, in adipocytes of women with PCOS, insulin stimulation was not associated with increased serine phosphorylation of GSK3β, in contrast to the case of control women. Tyrosine phosphorylation of GSK3β also was higher in women with PCOS, compared with in control women. Consistent with the phosphorylation data, GSK3β activity was elevated in PCOS adipocytes. Conclusion(s): These data suggest that GSK3β is hyperactivated and resistant to down-regulation by insulin in PCOS. By using physiologic approaches, we demonstrated that abnormal GSK3β regulation is a potential mechanism for the insulin resistance that is seen in some women with PCOS, which may contribute to their development of the syndrome.

KW - Glycogen synthase kinase

KW - insulin resistance

KW - phosphorylation

KW - polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=56649102159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56649102159&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.10.025

DO - 10.1016/j.fertnstert.2007.10.025

M3 - Article

C2 - 18178198

AN - SCOPUS:56649102159

VL - 90

SP - 2291

EP - 2297

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -